Philips and RealView Imaging recently completed a clinical study demonstrating the feasibility of using live 3D holographic visualization and interaction technology to guide minimally-invasive structural heart disease procedures. RealView’s technology was used to display interactive, real-time 3D holographic images acquired by Philips’ interventional X-ray and cardiac ultrasound systems.
In addition to viewing the patient’s heart on a 2D screen, doctors were able to view detailed dynamic 3D holographic images of the heart ’floating in free space’ during a minimally-invasive structural heart disease procedure, without using special eyewear. They were able to manipulate the projected 3D heart structures by touching the holographic volumes in front of them. The study demonstrated the potential of the technology to enhance the context and guidance of structural heart repairs.
The Yokneam, Israel based company says it plans to launch the system in 2015.